This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA520840; GEO: GSE126038 |
| Type | Umbrella project |
| Publications | Garcia-Recio S et al., "FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease.", J Clin Invest, 2020 Sep 1;130(9):4871-4887 |
| Submission | Registration date: 4-Feb-2019
Professor of Genetics, and Pathology & Laboratory Medicine; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill |
| Relevance | Superseries |
Project Data:
| Resource Name | Number
of Links |
|---|
| Publications |
| PubMed | 1 |
| PMC | 1 |
| Other datasets |
| GEO DataSets | 3 |
GEO Data Details| Parameter | Value |
|---|
| Data volume, Spots | 1264302 |
| Data volume, Processed Mbytes | 40 |
| Data volume, Supplementary Mbytes | 615 |
FGFR4 is a key regulator of tumor subtype differentiation in luminal breast cancer and metastatic disease encompasses the following 2 sub-projects:
| Project Type | Number of Projects |
| Transcriptome or Gene expression | 2 |
BioProject
accession | Organism | Title |
|---|
| PRJNA520842 | Homo sapiens | FGFR4 is a key regulator of tumor subtype differentiation in luminal breast cancer and metastatic disease [set 2] (Professor of Genetics, and...) | | PRJNA520843 | Homo sapiens | FGFR4 is a key regulator of tumor subtype differentiation in luminal breast cancer and metastatic disease [set 1] (Professor of Genetics, and...) |
|